申请人:Murakata Masatoshi
公开号:US09133174B2
公开(公告)日:2015-09-15
The present invention provides a novel method for producing a compound represented by general formula (VII) below or a pharmaceutically acceptable salt thereof or a synthetic intermediate thereof:
wherein R2 represents a hydrogen atom or a halogen atom, Rc represents a C1-6 alkyl group, X represents a group selected from a heteroaryl group etc., R11 represents an atom or group selected from a hydrogen atom, a halogen atom, a C1-6 alkyl group, etc., R16 and R17 each independently represent an atom or group selected from a hydrogen atom, a C1-6 alkyl group, etc., and R15 represents a hydrogen atom or a C1-6 alkyl group.
本发明提供了一种制备下列通式(VII)所代表的化合物或其药学上可接受的盐或合成中间体的新方法:
其中,R2代表氢原子或卤素原子,Rc代表C1-6烷基,X代表从杂环基等中选择的基团,R11代表从氢原子、卤素原子、C1-6烷基等中选择的原子或基团,R16和R17各自独立地代表从氢原子、C1-6烷基等中选择的原子或基团,而R15代表氢原子或C1-6烷基。